A new chemical approach to human ABO Histo-Blood group Type 2 antigens

Molecules

Volumn 19, Issue 1, 2014, Pages 414-437

  Hara, Atsushi ^a   Imamura, Akihiro ^a   Ando, Hiromune ^a,b   Ishida, Hideharu ^a   Kiso, Makoto ^a,b  

^a GIFU UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Blood group antigen; Glycosylation; Heyns rearrangement; Oligosaccharide

Indexed keywords

EPITOPE; TRISACCHARIDE;

ARTICLE; BLOOD GROUP ABO SYSTEM; CHEMISTRY; HUMAN;

ABO BLOOD-GROUP SYSTEM; EPITOPES; HUMANS; TRISACCHARIDES;

EID: 84893097244     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules19010414     Document Type: Article

References (53)

1. Stanley, P.; Cummings, R.D. Structures Common to Different Glycans. In Essentials of Glycobiology, 2nd ed.; Varki, A., Cummings, R.D., Esko, J.D., Freeze, H.H., Stanley, P., Bertozzi, C.R., Hart, G.W., Etzler, M.E., Eds.; Cold Spring Harbor: New York, NY, USA, 2009; Chapter 13, pp. 175-198.
2. Ravn, V.; Dabelsteen, E. Tissue distribution of histo-blood group antigens. APMIS 2000, 108, 1-28.
3. Mollicone, R.; Gibaud, A.; Francois, A.; Ratcliffe, M.; Oriol, R. Acceptor specificity and tissue distribution of three human a-3- fucosyltransferases. Eur. J. Biochem. 1990, 191, 169-176.
4. Meloncelli, P.; Lowary, T.L. Synthesis of ABO histo-blood group type I and II antigens. Carbohydr. Res. 2010, 345, 2305-2322.
5. Landsteiner, K. Cell Antigens. In The Specificity of Serological Reactions; Landsteiner, K., Ed.; Dover Publications, Inc.: New York, NY, USA, 1936; pp. 75-126.
6. Williamson, L.M.; Lowe, S.; Love, E.M.; Cohen, H.; Soldan, K.; McClelland, D.B.L.; Skacel, P.; Barbara, J.A.J. Serious hazards of transfusion (SHOT) initiative: Analysis of the first two annual reports. BMJ 1999, 319, 16-19.
7. Cooper, D.K.C. Xenoantigens and xenoantibodies. Xenotransplantation 1998, 5, 6-17.
8. Reid, M.E.; Bird, G.W.G. Associations between human red cell blood group antigens and disease. Transfus. Med. Rev. 1990, 4, 47-55.
9. Anstee, D.J. The relationship between blood groups and disease. Blood 2010, 115, 4635-4643.
10. O'Donnell, J.; Laffan, M.A. The relationship between ABO histo-blood group, factor VIII and von Willebrand factor. Transfus. Med. 2001, 11, 343-351.
11. Ruiz-Palacios, G.M.; Cervantes, L.E.; Ramos, P.; Chavez-Munguia, B.; Newburg, D.S. Campylobacter jejuni binds intestinal H(O) antigen (Fuca1,2Galß1,4GlcNAc), and fucosyloligosaccharides of human milk inhibit its binding and infection. J. Biol. Chem. 2003, 278, 14112-14120.
12. Rossez, Y.; Maes, E.; Darroman, T.L.; Gosset, P.; Ecobichon, C.; Curt, M.J.C.; Boneca, I.G.; Michalski, J.-C.; Robbe-Masselot, C. Almost all human gastric mucin O-glycans harbor blood group A, B or H antigens and are potential binding sites for Helicobacter pylori. Glycobiology 2012, 22, 1193-1206.
13. Lindesmith, L.; Moe, C.; Marionneau, S.; Ruvoen, N.; Jiang, X.; Lindblad, L.; Stewart, P.; LePendu, J.; Baric, R. Human susceptibility and resistance to Norwalk virus infection. Nat. Med. 2003, 9, 548-553.
14. Tan, M.; Jiang, X. Norovirus and its histo-blood group antigen receptors: An answer to a historical puzzle. Trends Microbiol. 2005, 13, 285-293.
15. Glinsky, G.V.; Ivanova, A.B.; Welsh, J.; McClelland, M. The role of blood group antigens in malignant progression, Apoptosis resistance, and metastatic behavior. Transfus. Med. Rev. 2000, 14, 326-350.
16. Pinho, S.S.; Carvalho, S.; Marcos-Pinto, R.; Magalhães, A.; Oliveira, C.; Gu, J.; Dinis-Ribeiro, M.; Carneiro, F.; Seruca, R.; Reis, C.A. Gastric cancer: Adding glycosylation to the equation. Trends Mol. Med. 2013, 19, 664-676.
17. Paulsen, H.; Kolár, C. Synthesis of the tetrasaccharide chains of the determinants of blood group substances A and B. Angew. Chem. Int. Ed. 1978, 17, 771.
18. Korchagina, E.Y.; Ryzhov, I.M.; Byrgazov, K.A.; Popova, I.S.; Pokrovsky, S.N.; Bovin, N.V. Block synthesis of blood group tetrasaccharides B (types 1, 3 and 4). Mendeleev Commun. 2009, 19, 152-154.
19. Ryzhov, I.M.; Korchagina, E.Y.; Popova, I.S.; Bovin, N.V. Block synthesis of A tetrasaccharides (types 1, 3 and 4) related to the human ABO blood group system. Carbohydr. Res. 2012, 351, 17-25.
20. Zimmermann, P.; Greilich, U.; Schmidt, R.R. Total synthesis of a hexaosyl ceramide glycolipid acting as a receptor for macrophage migration inhibiton-factor. Tetrahedron Lett. 1990, 31, 1849-1852.
21. Udodong, U.E.; Rao, C.S.; Fraser-Reid, B. n-Pentenyl glycosides in the efficient assembly of the blood group substance B tetrasaccahride. Tetrahedron 1992, 48, 4713-4724.
22. Deshpande, P.P.; Kim, H.M.; Zatorski, A.; Park, T.-K.; Ragupathi, G.; Livingston, P.O.; Live, D.; Danishefsky, S.J. Strategy in oligosaccharide synthesis: An application to a concise total synthesis of the KH-1 (adenocarcinoma) antigen. J. Am. Chem. Soc. 1998, 120, 1600-1614.
23. Bovin, N.V.; Zurabyan, S.É.; Khorlin, A.Y. Stereoselectivity in glycosylation by means of 2-Azido-2-desoxy-D-galactopyranose derivatives and the synthesis of the determinative oligosaccharide of blood group A, type 1. Russ. Chem. Bull. 1982, 31, 1023-1030.
24. Paulsen, H.; Kolár, C. Synthese der tetrasaccharid-ketten der type 2 der determinanten der blutgruppensubstanzen A und B. Tetrahedron Lett. 1979, 31, 2882-2884.
25. Milat, M.-L.; Sinäy, P. Synthesis of the tetrasaccharide O-A-L-fucopyranosyl-(12)-[O-A-Dgalactopyranosyl-(13)]-O-ß-D- galactopyranosyl-(14)-2-Acetamido-2-deoxy-D-glucopyranose, the antigenic determinant of human blood-group B (type 2). Carbohydr. Res. 1981, 92, 183-189.
26. Pazynina, G.V.; Tyrtysh, T.V.; Bovin, N.V. Synthesis of histo blood-group antigens A and B (type 2), xenoantigen Gala1-3Galß1-4GlcNAc and related type 2 backbone oligosaccharides as haptens in spacered form. Mendeleev Commun. 2002, 12, 143-145.
27. Lemieux, R.U.; Driquez, H. Chemical synthesis of 2-O-(a-L-fucopyranosyl)- 3-O-(a-Dgalactopyranosyl)-D-galactose. Terminal structure of the blood-group B antigenic determinant. J. Am. Chem. Soc. 1975, 97, 4069-4075.
28. Lemieux, R.U.; Bock, K.; Delbaere, L.T.J.; Koto, S.; Rao, V.S. The conformations of oligosaccharides related to the ABH and Lewis human blood determinants. Can. J. Chem. 1980, 58, 631-653.
29. Lemieux, R.U.; Abbas, S.Z.; Burzynska, M.H.; Ratcliffe, R.M. Syntheses of derivatives of N-Acetyl-D-lactosamine from D-lactal hexaacetate. Hexa-O-Acetyl-2-deoxy-2-phthalimide-ß-Dlactosyl chloride. Can. J. Chem. 1982, 60, 63-67.
30. Lemieux, R.U.; Abbas, S.Z.; Chung, B.Y. Syntheses of core chain trisaccharides related to human blood group antigenic determinants. Can. J. Chem. 1982, 60, 68-75.
31. Hindsgaul, O.; Norberg, T.; le Pendu, J.; Lemieux, R.U. Synthesis of type 2 human blood-group antigenic determinants. The H, X, and Y haptens and variations of the H type 2 determinant as probes for the combining site of the lectin I of Ulex europaeus. Carbohydr. Res. 1982, 109, 109-142.
32. Heyns, K.; Meinecke K.-H. Über bildung und darstellung von d-glucosamin aus fructose und ammoniak. Chem. Ber. 1953, 86, 1453-1462.
33. Wrodnigg, T.M.; Stütz, A.E. The Heyns rearrangement revisited: An exceptionally simple two-step chemical synthesis of D-lactosamine from lactulose. Angew. Chem. Int. Ed. 1999, 38, 827-828.
34. Stütz, A.E.; Dekany, G.; Eder, B.; Illaszewicz, C.; Wrodnigg, T.M. An exceptionally simple chemical synthesis of O-glycosylated D-glucosamine derivatives by Heyns rearrangement of the corresponding O-glycosyl fructoses. J. Carbohydr. Chem. 2003, 22, 253-265.
35. Shan, Y.; Oulaidi, F.; Lahmann, M. Lactosamine from lactulose via the Heyns arrangement: A practical protocol. Tetrahedron Lett. 2013, 54, 3960-3961.
36. Ohmae, M.; Takada, J.; Murakami, H.; Kimura, S. Rapid access to an orthogonally protected Lewis X derivative: An important building block for synthesis of Lewis antigens. Chem. Lett. 2011, 40, 438-439.
37. Depré, D.; Düffels, A.; Green, L.G.; Lenz, R.; Ley, S.V.; Wong, C.-H. Synthesis of glycans from the glycodelins: Two undeca-, two deca-, three nona-, an octa-And a heptasaccharide. Chem. Eur. J. 1999, 5, 3326-3340.
38. Hense, A.; Ley, S.V.; Osborn, H.M.I.; Owen, D.R.; Poisson, J.-F.; Warriner, S.L.; Wesson, K.E. Direct preparation of diacetals from 1,2-diketones and their use as 1,2-diol protecting groups. J. Chem. Soc. Perkin Trans. 1 1997, 2023-2031, doi:10.1039/A702497E.
39. Muramatsu, W. Chemo-And regioselective monosulfonylation of nonprotected carbohydrates catalyzed by organotin dichloride under mild conditions. J. Org. Chem. 2012, 77, 8083-8091.
40. Yu, B.; Tao, H. Glycosyl trifluoroacetimidates. Part 1: Preparation and application as new glycosyl donors. Tetrahedron Lett. 2001, 42, 2405-2407.
41. Yu, B.; Sun, J. Glycosylation with glycosyl N-phenyltrifluoroacetimidates (PTFAI) and a perspective of the future development of new glycosylation methods. Chem. Commun. 2010, 46, 4668-4679.
42. Iwayama, Y.; Ando, H.; Tanaka, H.; Ishida, H.; Kiso, M. Synthesis of the glycan moiety of ganglioside HPG-7 with an usual trimer of sialic acid as the inner sugar residue. Chem. Commun. 2011, 47, 9726-9728. The synthetic procedure for compound 12 derived from the known fucose derivative in this literature was described in the Experimental Section.
43. Ishiwata, A.; Munemura, Y.; Ito, Y. Synergistic solvent effect in 1,2-cis-glycoside formation. Tetrahedron 2008, 64, 92-102.
44. Konradsson, P.; Mootoo, D.R.; McDevitt, R.E.; Fraser-Reid, B. Iodonium ion generated in situ from N-iodosuccimide and trifluoromethanesulphonic acid promotes direct linkage of 'disarmed' pent-4-enyl glycosides. J. Chem. Soc. Chem. Commun. 1990, 270-272.
45. Veeneman, G.H.; van Leeuwen, S.H.; van Boom, J.H. Iodonium ion promoted reactions at the anomeric centre. II An efficient thioglycoside mediated approach toward the formation of 1,2-trans linked glycosides and glycosidic esters. Tetrahedron Lett. 1990, 31, 1331-1334.
46. Imamura, A.; Ando, H.; Ishida, H.; Kiso, M. Ganglioside GQ1b: Efficient total synthesis and the expansion to synthetic derivatives to elucidate its biological roles. J. Org. Chem. 2009, 74, 3009-3023.
47. Demchenko, A.V. 1,2-cis O-Glycosylation: Methods, strategies, principles. Curr. Org. Chem. 2003, 7, 35-79.
48. Imamura, A.; Ando, H.; Korogi, S.; Tanabe, G.; Muraoka, O.; Ishida, H.; Kiso, M. Di-tert-butylsilylene (DTBS) group-directed a-selective galactosylation unaffected by C-2 participating functionalities. Tetrahedron Lett. 2003, 44, 6725-6728.
49. Imamura, A.; Kimura, A.; Ando, H.; Ishida, H.; Kiso, M. Extended applications of di-tert-butylsilylene-directed a-predominant galactosylation compatible with C2-participating groups toward the assembly of various glycosides. Chem. Eur. J. 2006, 12, 8862-8870.
50. Imamura, A.; Ando, H.; Ishida, H.; Kiso, M. DTBS(di-tert-butylsilylene)- directed a-galactosylation for the synthesis of biologically relevant glycans. Curr. Org. Chem. 2008, 12, 675-689.
51. Imamura, A.; Ando, H.; Ishida, H.; Kiso, M. DTBS effect: The unique sterically driven director for a-galactosylation. Heterocycles 2008, 76, 883-908. The synthetic procedure for compound 20 was described in the Experimental Section.
52. Furusawa, K. Removal of cyclic di-t-butylsilanediyl protecting groups using tributylamine hydrofluoride (TBAHF) reagent. Chem. Lett. 1989, 509-510.
53. Malet, C.; Hindsgaul, O. Generation of molecular diversity on N-Acetyllactosamine via O-cyanomethyl ethers. Carbohydr. Res. 1997, 303, 51-65.